INVESTIGATION OF THE ELIMINATION OF DABIGATRAN BY HAEMODIALYSIS IN PATIENTS WITH END STAGE RENAL DISEASE (ESRD)

被引：0
|
作者：
Haertter, S. [1 ]
Trenmmel, M. [1 ]
Nehmiz, G. [4 ]
Liesenfeld, K. [1 ]
Moschetti, V. [1 ]
Peters, H. [2 ]
Wagner, F. [3 ]
Formella, S. [5 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Translat Med, Ingelheim, Germany
[2] Charite, Dept Nephrol, Berlin, Germany
[3] Charite Res Org, Berlin, Germany
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[5] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [11] ULTRAFILTRATION IN PATIENTS WITH END STAGE RENAL-DISEASE - (ESRD)
    BOSCH, J
    GLABMAN, S
    KAHN, T
    GERONEMUS, R
    ALBERTINI, BV
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1979, (SEP): : 119 - 119
  • [12] Hypoglycaemia remains the main challenge in the management of patients receiving haemodialysis for end stage renal disease (ESRD) due to diabetes
    Williams, L.
    Kalathil, D.
    Zaidi, R.
    Sharma, D.
    DIABETIC MEDICINE, 2016, 33 : 160 - 160
  • [13] End-stage renal disease (ESRD) in patients with eating disorders
    AbdelRahman, EM
    Moorthy, AV
    CLINICAL NEPHROLOGY, 1997, 47 (02) : 106 - 111
  • [14] Mitochondrial Morphology in Patients with End-stage Renal Disease (ESRD)
    Gamboa, Jorge
    Derer, Chelsea
    Ikizler, T. Alp
    FASEB JOURNAL, 2015, 29
  • [15] HDL is dysfunctional in patients with end-stage renal disease (ESRD)
    Schuchardt, M.
    Toelle, M.
    Huang, T.
    Wiedon, A.
    Van Der Giet, M.
    CARDIOVASCULAR RESEARCH, 2010, 87 : S83 - S83
  • [16] Smoking and hyperparathyroidism in patients with end-stage renal disease (ESRD)
    Tripepi, Giovanni
    Mattace-Raso, Francesco
    Pizzini, Patrizia
    Cutrupi, Sebastiano
    Witteman, Jacqueline
    Zoccali, Carmine
    Mallamaci, Francesca
    JOURNAL OF NEPHROLOGY, 2012, 25 (01) : 75 - 83
  • [17] Foot morbidity in patients with End Stage Renal Disease (ESRD) on dialysis
    Schembri, N.
    Formosa, C.
    DIABETIC MEDICINE, 2022, 39
  • [18] Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD)
    Qunibi, WY
    KIDNEY INTERNATIONAL, 2004, 66 : S8 - S12
  • [19] Psychological problems of end-stage renal disease (ESRD) patients
    Kikuchi, M
    Fukunishi, I
    CUTTING EDGE MEDICINE AND LIAISON PSYCHIATRY: PSYCHIATRIC PROBLEMS OF ORGAN TRANSPLANTATION, CANCER, HIV/AIDS AND GENETIC THERAPY, 1999, 1174 : 159 - 167
  • [20] Acylcarnitine profile in end-stage renal disease (ESRD) patients
    Sulyok, E.
    Csiky, B.
    Bene, J.
    Wittmann, I.
    Melegh, B.
    PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1591 - 1592
12345